Ahmed Elkhanany

2.4k total citations
25 papers, 527 citations indexed

About

Ahmed Elkhanany is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ahmed Elkhanany has authored 25 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Ahmed Elkhanany's work include Advanced Breast Cancer Therapies (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Ferroptosis and cancer prognosis (3 papers). Ahmed Elkhanany is often cited by papers focused on Advanced Breast Cancer Therapies (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Ferroptosis and cancer prognosis (3 papers). Ahmed Elkhanany collaborates with scholars based in United States, India and Egypt. Ahmed Elkhanany's co-authors include Kazuaki Takabe, Mateusz Opyrchal, Shamit K. Dutta, Krishnendu Pal, Debabrata Mukhopadhyay, Fergus J. Couch, Wenyan Ji, Yara Abdou, Kristopher Attwood and Erica Stringer-Reasor and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ahmed Elkhanany

21 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmed Elkhanany United States 9 236 170 168 112 68 25 527
Silvia Bolzonello Italy 6 235 1.0× 110 0.6× 138 0.8× 137 1.2× 15 0.2× 13 435
Henry Gómez Peru 8 273 1.2× 105 0.6× 152 0.9× 124 1.1× 10 0.1× 20 472
Marcela Mrhalová Czechia 15 218 0.9× 111 0.7× 316 1.9× 144 1.3× 13 0.2× 48 594
Merry Tetef United States 14 269 1.1× 118 0.7× 147 0.9× 119 1.1× 16 0.2× 29 581
Jamie N. Holloway United States 7 308 1.3× 194 1.1× 187 1.1× 73 0.7× 12 0.2× 7 512
Xiao‐Dong Jiao China 17 383 1.6× 213 1.3× 291 1.7× 338 3.0× 7 0.1× 56 821
Shengguang Yuan China 15 231 1.0× 259 1.5× 469 2.8× 101 0.9× 13 0.2× 21 728
Eun Yong Choi United States 14 223 0.9× 104 0.6× 311 1.9× 92 0.8× 8 0.1× 30 562
Nikolaos Syrigos Greece 12 279 1.2× 91 0.5× 187 1.1× 190 1.7× 5 0.1× 61 599

Countries citing papers authored by Ahmed Elkhanany

Since Specialization
Citations

This map shows the geographic impact of Ahmed Elkhanany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed Elkhanany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed Elkhanany more than expected).

Fields of papers citing papers by Ahmed Elkhanany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmed Elkhanany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed Elkhanany. The network helps show where Ahmed Elkhanany may publish in the future.

Co-authorship network of co-authors of Ahmed Elkhanany

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmed Elkhanany. A scholar is included among the top collaborators of Ahmed Elkhanany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmed Elkhanany. Ahmed Elkhanany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zavras, Phaedon D., Luciane T. Kagohara, Won Jin Ho, et al.. (2025). Spatial transcriptomic analysis of the ImmunoADAPT trial: Neoadjuvant endocrine therapy combined with palbociclib and avelumab in early-stage ER-positive breast cancer.. Journal of Clinical Oncology. 43(16_suppl).
2.
3.
Williams, Courtney, Ahmed Elkhanany, Katia Khoury, et al.. (2024). Therapeutic Clinical Trial Eligibility and Enrollment among Women with Breast Cancer: Implications for Understanding Trial Disparities. Annals of Surgical Oncology. 32(3). 2038–2044.
4.
Zavras, Phaedon D., Ashley Cimino‐Mathews, Lisa K. Jacobs, et al.. (2024). Abstract PO1-01-09: Neoadjuvant endocrine therapy and avelumab with or without palbociclib in stage II/III endocrine receptor-positive breast cancer: the ImmunoADAPT trial. Cancer Research. 84(9_Supplement). PO1–1. 1 indexed citations
5.
Damodaran, Senthil, Ciara C. O’Sullivan, Ahmed Elkhanany, et al.. (2023). Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2− breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2. Annals of Oncology. 34(12). 1131–1140. 25 indexed citations
6.
Siegal, Gene P., Ahmed Elkhanany, Lei Huo, et al.. (2023). Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma. Cancers. 15(9). 2524–2524. 2 indexed citations
7.
Vaklavas, Christos, Erica Stringer-Reasor, Ahmed Elkhanany, et al.. (2023). A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer. Breast Cancer Research and Treatment. 198(2). 217–229. 2 indexed citations
8.
9.
Blau, Sibel, Julio A. Peguero, Halle C. F. Moore, et al.. (2023). Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model. JCO Clinical Cancer Informatics. 7(7). e2200164–e2200164. 1 indexed citations
10.
Vidula, Neelima, Shumei Kato, Caroline Weipert, et al.. (2022). Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer. npj Breast Cancer. 8(1). 117–117. 8 indexed citations
11.
Elkhanany, Ahmed, et al.. (2022). Effect of prior treatments on post-CDK 4/6 inhibitor survival in hormone receptor-positive breast cancer. Breast Cancer Research and Treatment. 197(3). 673–681. 5 indexed citations
12.
Stringer-Reasor, Erica, Ahmed Elkhanany, Katia Khoury, Melissa A. Simon, & Lisa A. Newman. (2021). Disparities in Breast Cancer Associated With African American Identity. American Society of Clinical Oncology Educational Book. 41(41). e29–e46. 45 indexed citations
13.
Yao, Song, Ting‐Yuan David Cheng, Ahmed Elkhanany, et al.. (2020). Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion. JNCI Journal of the National Cancer Institute. 113(8). 1036–1043. 59 indexed citations
14.
Abdou, Yara, Ahmed Elkhanany, Kristopher Attwood, et al.. (2019). Primary and secondary breast angiosarcoma: single center report and a meta-analysis. Breast Cancer Research and Treatment. 178(3). 523–533. 57 indexed citations
15.
Khalil, Maya, Ahmed Elkhanany, Yuanquan Yang, et al.. (2019). The tumor microenvironment in EGFR-driven loco-regional lung adenocarcinoma can predict higher risk of recurrence.. Journal of Clinical Oncology. 37(15_suppl). 8521–8521. 2 indexed citations
16.
Elkhanany, Ahmed, Eriko Katsuta, & Kazuaki Takabe. (2018). Racial disparity in breast cancer immune microenvironment.. Journal of Clinical Oncology. 36(15_suppl). 1081–1081. 4 indexed citations
17.
Leon‐Ferre, Roberto A., Mei‐Yin C. Polley, Heshan Liu, et al.. (2017). Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer. Breast Cancer Research and Treatment. 167(1). 89–99. 73 indexed citations
18.
Abdelfattah, Nizar Saleh, et al.. (2015). Clinical correlates of common corneal neovascular diseases: a literature review.. SHILAP Revista de lepidopterología. 8(1). 182–93. 45 indexed citations
19.
Bhattacharya, Santanu, Krishnendu Pal, Anil Kumar Sharma, et al.. (2014). GAIP Interacting Protein C-Terminus Regulates Autophagy and Exosome Biogenesis of Pancreatic Cancer through Metabolic Pathways. PLoS ONE. 9(12). e114409–e114409. 62 indexed citations
20.
Sinha, Sutapa, Krishnendu Pal, Ahmed Elkhanany, et al.. (2012). Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo. International Journal of Cancer. 132(5). 1201–1212. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Bolzonello Breakdown of academic impact, for papers by Henry Gómez Breakdown of academic impact, for papers by Marcela Mrhalová Breakdown of academic impact, for papers by Merry Tetef Breakdown of academic impact, for papers by Jamie N. Holloway Breakdown of academic impact, for papers by Xiao‐Dong Jiao Breakdown of academic impact, for papers by Shengguang Yuan Breakdown of academic impact, for papers by Eun Yong Choi Breakdown of academic impact, for papers by Nikolaos Syrigos
Rankless by CCL
2026